Botanical raw material · identity
Supplier COA attached · 21 CFR Part 111
- Lot rejected · supplier notifiedSupplier Quality
- Adulteration check · CAPA openedQuality
- Replacement lot · retestedMatches reference
Built for dietary-supplement brand owners and contract manufacturers under 21 CFR Part 111, where incoming identity testing, batch record completeness, and specification setting have to stay traceable, and hold up in an FDA inspection or an NSF surveillance audit.
Built for dietary-supplement GMP teams
Incumbents track batch and document status. Unifize reconstructs the decision trace across every function a deviation or release touched: the identity testing, the spec verification, and the reasoning an inspector actually asks for.
The reconstruction always lands on someone. Find your seat, and see what you own when the trace has to hold up at a Part 111 inspection or an NSF surveillance audit.
Every release and deviation decision stays reconstructable.
Incoming material release and in-process holds move on one accountable thread.
Label claims, structure-function substantiation, and NDI notification stay tied to the evidence that supports them.
Part 111 GMP evidence and NSF, USP, and Informed Sport certification records are captured where they happen.
Blend and formulation changes move fast with their specifications and identity methods sealed to the record.
Each runs with Part 111 and your NSF or USP program built in. Start with the one that costs you most.
From the nonconformance on the floor to a CAPA closed before it ages into a 483.
Supplier COAs checked against spec and tied to the lot, deeper for botanicals.
Incoming identity testing held on one thread, from receipt to release.
Consumer complaints triaged and linked to CAPA; recalls run as one event.
Unifize sits alongside the ERP, QMS, LIMS, and identity-testing software you already run. It replaces the ungoverned channels where the decision trace goes missing, not your systems of record.
Every approval is captured as an attributable, time-stamped electronic signature, so the decision trace is a record an FDA inspector or an NSF auditor can follow, not a reconstruction after the fact.
Incoming identity testing (HPTLC, HPLC, FTIR), batch record completeness, specification setting and verification, and NSF or USP audit readiness are walked through with your team before anything touches a controlled record.
Enforcement, retailer, and audit deadlines, not internal outcomes. Each one routes to the process that answers it and the team that owns the response.
Routes to CAPA & Effectiveness · owned by Quality
Routes to Batch Record Review & Release · owned by Quality
Routes to Certification Management (NSF / USP) · owned by Quality Systems & Audit
A capsule and tablet contract manufacturer and a supplement brand's quality team, on ingredient review, specs, master formulas, contract manufacturers, lot release and retained samples. Figures are as stated on film.
Erica BennermanNutritional SupplementsOne ingredient's review cut from an hour to half or less
Biovation LabsJesse Kolstad, Director of QualityRetests and labs consolidated, testing cost down 50%
Mikala HukkaNutritional SupplementsMaster formulas from approved materials, at least 50% faster
Erica BennermanNutritional SupplementsThe contract manufacturer answers inside Unifize, fast
Biovation LabsJesse Kolstad, Director of QualityLot release that took days now takes minutes
Biovation LabsJesse Kolstad, Director of QualityRetained samples tied to each lot, pulled immediatelyPick a release or identity-testing decision you could not replay at the last inspection. We will reconstruct it live.